News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,709 Results
Type
Article (39837)
Company Profile (248)
Press Release (659624)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204377)
Career Advice (2009)
Deals (35442)
Drug Delivery (95)
Drug Development (81111)
Employer Resources (172)
FDA (16209)
Job Trends (14863)
News (345522)
Policy (32566)
Tag
Academia (2565)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49494)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (124)
Approvals (16212)
Artificial intelligence (253)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11641)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2257)
Cardiovascular disease (174)
Career advice (1678)
Career pathing (31)
CAR-T (152)
Cell therapy (424)
Cervical cancer (19)
Clinical research (66023)
Collaboration (832)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2592)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2206)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6369)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86725)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112560)
Executive appointments (722)
FDA (17471)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (747)
Gene editing (104)
Generative AI (19)
Gene therapy (303)
GLP-1 (709)
Government (4417)
Grass and pollen (4)
Guidances (67)
Healthcare (18827)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2734)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (312)
IPO (16518)
IRA (40)
Job creations (3631)
Job search strategy (1423)
Kidney cancer (10)
Labor market (38)
Layoffs (468)
Leadership (18)
Legal (7914)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (304)
MASH (67)
Medical device (13404)
Medtech (13409)
Mergers & acquisitions (19468)
Metabolic disorders (685)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1913)
NextGen: Class of 2025 (6521)
Non-profit (4482)
Now hiring (39)
Obesity (364)
Opinion (205)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57339)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20567)
Phase II (29075)
Phase III (21663)
Pipeline (1203)
Policy (139)
Postmarket research (2564)
Preclinical (8761)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (380)
Real estate (5908)
Recruiting (65)
Regulatory (22305)
Reports (46)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3582)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (40)
The Weekly (29)
Vaccines (691)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (142)
Last 7 days (901)
Last 30 days (2597)
Last 365 days (32778)
2025 (10714)
2024 (35252)
2023 (40112)
2022 (51217)
2021 (55761)
2020 (54134)
2019 (46589)
2018 (35058)
2017 (32141)
2016 (31538)
2015 (37596)
2014 (31361)
2013 (26393)
2012 (28639)
2011 (29295)
2010 (27364)
Location
Africa (720)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37937)
Australia (6199)
California (6128)
Canada (2013)
China (523)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81395)
Florida (911)
Georgia (206)
Idaho (57)
Illinois (535)
India (25)
Indiana (307)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (896)
Massachusetts (4579)
Michigan (220)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1726)
New Mexico (28)
New York (1745)
North Carolina (967)
North Dakota (8)
Northern California (2680)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1375)
Puerto Rico (12)
Rhode Island (33)
South America (1098)
South Carolina (23)
South Dakota (1)
Southern California (2301)
Tennessee (101)
Texas (906)
United States (23122)
Utah (180)
Virginia (145)
Washington D.C. (61)
Washington State (550)
West Virginia (3)
Wisconsin (54)
699,709 Results for "collagen matrix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Taiwan’s ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
April 13, 2025
·
2 min read
Press Releases
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
August 1, 2024
·
2 min read
Biotech Bay
Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences
Collagen Matrix, Inc. announced it has changed its name to Regenity Biosciences and unveiled a new visual identity and website.
March 28, 2023
·
3 min read
Press Releases
Boston Pharmaceuticals to Present the Effect of Efimosfermin Alfa on Collagen Biomarkers in Patients with F2 and F3 MASH at EASL Congress 2025
April 28, 2025
·
6 min read
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
Axogen, Inc. announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.
June 24, 2024
·
6 min read
Press Releases
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting
March 24, 2025
·
2 min read
Press Releases
Atreon Orthopedics Announces FDA 510(k) Clearance and Full Market Launch of BioCharge® Autobiologic Matrix for Rotator Cuff Repair
February 20, 2025
·
3 min read
Deals
Collagen Matrix Acquires Polyganics
Collagen Matrix, Inc., a global leader in regenerative medicine and a Linden Capital Partners portfolio company, announced the acquisition of Polyganics, B.V. Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices.
October 5, 2022
·
5 min read
Pharm Country
Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market
Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance for a new Fibrillar Collagen Wound Dressing.
June 28, 2022
·
3 min read
Business
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), announced today that is has signed an exclusive license agreement with Tufts University (“Tufts”) to develop and commercialize patented technology covering 18 unique collagen peptides.
January 3, 2024
·
5 min read
1 of 69,971
Next
